HTG Molecular Diagnostics, Inc. HTGMQ OTC

Other OTC • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score

32/100

1/6 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

HTG Molecular Diagnostics, Inc. (HTGMQ) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 31/100 其中 1/7 项标准通过。

SharesGrow 7-Criteria Score

32/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

✓

未來

100/100

Analyst consensus

→ Forecast

✗

过去

0/100

→ Income

健康

50/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

14/100

→ Income

✗

成长

15/100

→ Income

✗

收入

10/100

→ Income

估值概览 — HTGMQ

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.00

EV/EBITDA0.0

每股数据

EPS (TTM)$-24.28

每股账面价值$0.00

每股营收$7.16

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2013	$-6,354.98	$2.24M	$-11.77M	-524.7%
2014	$-7,536.94	$3.33M	$-13.96M	-419.3%
2015	$-905.40	$4.04M	$-21.4M	-529.4%
2016	$-658.95	$5.13M	$-26.04M	-507.3%
2017	$-322.04	$14.76M	$-18.96M	-128.5%
2018	$-107.61	$21.5M	$-16.45M	-76.5%
2019	$-91.17	$19.2M	$-19.3M	-100.5%
2020	$-54.12	$8.55M	$-20.87M	-244.1%
2021	$-29.66	$8.91M	$-17.15M	-192.5%
2022	$-24.28	$6.37M	$-21.59M	-339.2%